Back to Search
Start Over
Successful Treatment of Primary Amoebic Meningoencephalitis Using a Novel Therapeutic Regimen Including Miltefosine and Voriconazole.
- Source :
-
Acta parasitologica [Acta Parasitol] 2022 Sep; Vol. 67 (3), pp. 1421-1424. Date of Electronic Publication: 2022 Jul 21. - Publication Year :
- 2022
-
Abstract
- The genus Naegleria consists of free-living amoebae widely distributed worldwide in soil and freshwater habitats. Primary amoebic meningoencephalitis (PAM) is an uncommon and most likely fatal disease. The incubation period is approximately 7 days. The first symptoms are headache, nasal congestion, fever, vomiting, stiff neck within 3-4 days after the first symptoms, confusion, abnormal behavior, seizures, loss of balance and body control, coma, and death. We describe the case of a child who presented with PAM due to Naegleria sp., fully recovered from the infection without apparent sequels after treatment with a regimen that included miltefosine and voriconazole.<br /> (© 2022. The Author(s) under exclusive licence to Witold Stefański Institute of Parasitology, Polish Academy of Sciences.)
- Subjects :
- Child
Humans
Phosphorylcholine analogs & derivatives
Phosphorylcholine therapeutic use
Voriconazole therapeutic use
Amebiasis diagnosis
Amebiasis drug therapy
Central Nervous System Protozoal Infections diagnosis
Central Nervous System Protozoal Infections drug therapy
Naegleria
Naegleria fowleri
Subjects
Details
- Language :
- English
- ISSN :
- 1896-1851
- Volume :
- 67
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Acta parasitologica
- Publication Type :
- Academic Journal
- Accession number :
- 35861895
- Full Text :
- https://doi.org/10.1007/s11686-022-00591-9